Advances have allowed for the creation of bispecific, ‘Fc-silenced,’ and other specialized antibody reagents tailored to specific research needs. These engineered antibodies are deepening our understanding of complex biological systems and accelerating research that informs the development of next-generation cell and gene therapies.